320
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis

, , &
Pages 2545-2551 | Published online: 28 Mar 2019

References

  • NaQGuokojunLyckeMKristjansdottirBSundfeldtKMeta-analysis of expression levels of epididymal protein 4 in ovarian cancer serumJ Chinese Cancer Prevent2012191612581262
  • QingLXiaolingSYangYuqinResearch progress of ROMA in early diagnosis of ovarian epithelial carcinomaAdv Mod Biomed Sci2011112449995000
  • LiDGuJZhaoSChanges in serum HE4 and CA125 levels in patients with endometrial cancerShandong Med20175737375
  • ChiLZhouxiaoyingHuangruiyuDiagnostic value of serum HE4, CA125, and ROMA index in ovarian cancerChinese Maternal and Child Health20174850
  • YangSLuWZhengYAnalysis of the diagnosis of ovarian cancer by serum CA125, HE4 combined ROMA indexMed Clin2016131419311933
  • XieWLinXChenWDiagnostic value of serum CA125, HE4 detection and ROMA model in malignant ovarian cancerInt J Test Med20162435033504
  • LeiZXiaoJXieHHE4 and CA125 combined application of the ROMA index to the diagnostic value of pelvic massesHarbin Pharmaceut201535s15556
  • FarzanehFHonarvarZYaraghiMPreoperative evaluation of risk of ovarian malignancy algorithm index in prediction of malignancy of adnexal massesIran Red Crescent Med J2014166e1718525068046
  • HeHJiangLHuRApplication value of serum HE4 level and ROMA index in ovarian cancer diagnosisJ Gannan Med Coll20146846848
  • YangHYuJWuYThe significance of ROMA in ovarian cancer diagnosisJiangsu Med2014401619051907
  • RenHongyingHuangWeicheng XiaoyuThe value of serum HE4 joint CA125 detection in risk assessment of ovarian cancerChina Health Ind201421177178
  • LiJValue of serum human epididymis secretory protein 4, CA125 and ROMA [D] (Risk of Ovarian Malignancy Algorithm)in the diagnosis of pelvic massSouthern Medical University2014 Chinese
  • HuoYDiscussion of HE4, CA125 and ROMA diagnstic value of serum index in epithelial ovarian cacer[D]Xinjiang Medical University2014
  • StiekemaALokCAKenterGGA predictive model combining human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancerGynecol Oncol20141323573577 Chinese24418200
  • PanYLinXHeXThe application value of serum HE4 and CA125 joint detection in the risk assessment of malignant ovarian cancer in pelvic mass patientsInt J Test Med2013345543544
  • XieZWangHLiuQApplication of serum HE4 and CA125 joint detection in the risk assessment of epithelial ovarian cancerJ Clin Milit Med2012402392394
  • BandieraERomaniCSpecchiaCSerum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer managementCancer Epidemiol Biomarkers Prev201120122496250622028406
  • ChenYHermioneSongZSecretion of serum human epididymis protein 4 and CA125 in ovarian tumors and ovarian cancer risk model in the differential diagnosis valueJ Suzhou University, Med Sci2010304795798
  • MooreRGMcMeekinDSBrownAKA novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massGynecol Oncol20091121404618851871
  • PaulsenTKjaerheimKKaernJTretliSTropéCImproved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitalsInt J Gynecol Cancer200616Suppl 1111716515561
  • JingLPengQpengA meta-analysis of clinical value in ovarian cancer diagnosisPractical Obstetrics and Gynecology2015313209213
  • LyckeMKristjansdottirBSundfeldtKA multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy indexGynecol Oncol2018151115916530149898
  • HuyNVQvan KhoaVTamLMTamLMStandard and optimal cut-off values of serum CA-125, HE4 and ROMA in preoperative prediction of ovarian cancer in VietnamGynecol Oncol Rep20182511011430109256
  • Al MusalhiKAl KindiMAl AisaryFEvaluation of HE4, CA-125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) in the preoperative assessment of patients with adnexal massOman Med J201631533634427602187
  • KarlsenMASandhuNHøgdallCEvaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic massGynecol Oncol2012127237938322835718
  • DikmenZGColakADoganPTuncerSAkbiyikFDiagnostic performances of CA125, HE4, and ROMA index in ovarian cancerEur J Gynaecol Oncol201536445746226390703
  • Van GorpTVeldmanJvan CalsterBSubjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal massesEur J Cancer201248111649165622226481
  • LiJWangXQuWWangJJiangSWComparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: a meta-analysisClinica Chimica Acta2019488215220